roundup speed olie i vand emulsion
evergreen garden care Österreich gmbh - pelargonsyre - olie i vand emulsion - 43,1 g/l pelargonsyre
prevymis
merck sharp & dohme b.v. - letermovir - cytomegalovirusinfektioner - antivirale midler til systemisk anvendelse - prevymis er indiceret til forebyggelse af cytomegalovirus (cmv) reaktivering og sygdom i voksen cmv-seropositive modtagere [r +] af en allogen hæmatopoietisk stamcelletransplantation (hsct). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antivirale agenter.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andre antineoplastiske midler - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
lentagran 45 wp vanddispergerbart pulver
belchim crop protection nv/sa - pyridat - vanddispergerbart pulver - 450 g/kg pyridat
proman suspensionskoncentrat
belchim crop protection nv/sa - metobromuron - suspensionskoncentrat - 500 g/l metobromuron
admiral 10 ec emulsionskoncentrat
sumitomo chemical agro europe s.a. - pyriproxyfen - emulsionskoncentrat - 100 g/l pyriproxyfen
milbeknock emulsionskoncentrat
belchim crop protection nv/sa - milbemectin - emulsionskoncentrat - 9,3 g/l milbemectin
turex wp vanddispergerbart pulver
mitsui agriscience international s.a./b.v. - bacillus - vanddispergerbart pulver - 500 g/kg bacillus thuringiensis subsp. aizawai, strain gc-91
ranman suspensionskoncentrat
isk biosciences products inc. - cyazofamid - suspensionskoncentrat - 400 g/l cyazofamid